Max Healthcare Approves Dividend, Lucknow Hospital Expansion, and FY26 Results

Max Healthcare Institute Ltd announced that its Board of Directors has approved a final dividend of ₹2 per equity share and a major expansion project for its Lucknow facility.

Key Decisions Made

At a meeting on May 21, 2026, the Board of Directors of Max Healthcare Institute Limited approved the audited standalone and consolidated financial results for the fiscal year ending March 31, 2026. They recommended a final dividend of ₹2 per equity share for FY 2025-26. The board also gave the go-ahead for Phase-I construction of the Max Super Specialty Hospital in Lucknow. This new facility will have 712 beds and is expected to take 36 months to complete, with an estimated cost of ₹1,400 Cr.

Other approvals included the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Accountants for FY 2026-27 and Mr. Anil Kumar Bhatnagar as a Non-Executive Director for three years starting October 1, 2026. In a significant move, the board approved the re-classification of Radiant Life Care Hospital Foundation from 'Promoter Group' to 'Public' category, pending necessary stock exchange approvals. The company also plans to shift its registered office from Maharashtra to Haryana, subject to member and regulatory consent.

Why These Actions Matter

The dividend payout provides direct value to shareholders. The Lucknow hospital expansion signals Max Healthcare's commitment to growth and increasing its healthcare capacity in a key region, which is expected to boost future revenue. The continuity in leadership and financial oversight is ensured by the re-appointments. The proposed changes in promoter classification and the registered office location are notable structural shifts that could influence corporate governance and the company's operational footprint.

Company Background

Max Healthcare Institute Limited is a major integrated healthcare provider in India. The company has been expanding its presence through both organic growth and strategic acquisitions. The Lucknow hospital project is a significant greenfield investment aimed at meeting the rising demand for advanced medical services.

What Happens Next

Shareholders will vote on the final dividend at the upcoming Annual General Meeting (AGM). Construction of the Lucknow hospital will begin, with completion targeted in three years. The company will seek the required approvals for the promoter re-classification and the registered office relocation. Mr. Bhatnagar will continue his directorial duties.

Potential Risks

Timelines for the office shift and promoter re-classification could be affected by delays in obtaining regulatory approvals. Potential cost overruns or construction delays for the Lucknow hospital project are also risks to consider. Max Healthcare's ability to effectively integrate new facilities and manage operational costs will be vital for the expansion's success.

Industry Context

Max Healthcare operates within a competitive hospital sector that includes companies like Apollo Hospitals, Fortis Healthcare, and Narayana Health. Expanding facilities and capacity is a common strategy for these providers to grow market share and enhance their service offerings.

Key Timelines

The audited financial results for the year ending March 31, 2026, have been approved. The dividend payment is expected within 30 days of the AGM. The Lucknow hospital construction is planned for completion within 36 months. Mr. Bhatnagar's new term as director begins October 1, 2026.

Investor Focus Points

Investors will closely monitor the AGM outcome for dividend approval and any updates on the Lucknow hospital construction. Key approvals from stock exchanges for the re-classification and regulatory clearances for the office shift will also be important points to track.